Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
06:46pm, Tuesday, 14'th Apr 2026
Viking Therapeutics, Inc. (VKTX) reached $35.52 at the closing of the latest trading day, reflecting a +1.46% change compared to its last close.
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Tuesday, 14'th Apr 2026
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Viking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth Knowing
06:51pm, Monday, 13'th Apr 2026
Viking Therapeutics, Inc. (VKTX) concluded the recent trading session at $35.01, signifying a +2.19% move from its prior day's close.
Viking Therapeutics to Participate at Upcoming Investor Conferences
07:30am, Friday, 10'th Apr 2026
SAN DIEGO, April 10, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic an
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts
06:46pm, Monday, 06'th Apr 2026
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $33.93, representing a -2.5% change from its previous close.
SG Americas Securities LLC Sells 26,191 Shares of Viking Therapeutics, Inc. $VKTX
04:47am, Sunday, 05'th Apr 2026
SG Americas Securities LLC lessened its holdings in shares of Viking Therapeutics, Inc. (NASDAQ: VKTX) by 27.3% during the fourth quarter, according to the company in its most recent Form 13F filing w
Better Healthcare Stock to Own in a Recession: Defensive or Growth?
07:45am, Saturday, 04'th Apr 2026
Defensive healthcare stocks such as Johnson & Johnson and CVS tend to outperform in recessions. Growth healthcare stocks offer higher risk and potential reward, less tied to economic cycles.
Where Will Viking Therapeutics Stock Be in 10 Years?
03:26pm, Friday, 03'rd Apr 2026
Viking Therapeutics has a shot at becoming a leader in the weight-loss market. However, the company's quest could run into significant obstacles.
These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target
07:35am, Wednesday, 01'st Apr 2026
The GLP-1 revolution has reshaped biopharma M&A strategy. With Novo Nordisk and Eli Lilly generating tens of billions in annual obesity drug revenue, large-cap acquirers are scouring the biotech lands
2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More
07:38am, Tuesday, 31'st Mar 2026
There are some tempting bargains if you know where to look.
Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors
06:51pm, Monday, 30'th Mar 2026
In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $29.94, indicating a -7.95% shift from the previous trading day.
1 Reason This Biotech Stock Could Triple Before Year-End
12:30am, Sunday, 29'th Mar 2026
Viking Therepeutics' VK2735 candidate is a dark horse contender among GLP-1 weight loss drugs. If upcoming late-stage clinical trial results prove positive, Viking's value as a takeover target could r
VKTX Finishes Enrollment in Second Late-Stage Study on Obesity Drug
11:01am, Friday, 27'th Mar 2026
Viking Therapeutics climbs after it completes enrollment in the second phase III obesity study for VK2735 and advances its bid in a fast-growing, competitive weight-loss market.
Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
07:05am, Thursday, 26'th Mar 2026
78-Week Study Evaluating Subcutaneous VK2735 in Adults with Obesity and Type 2 Diabetes SAN DIEGO, March 26, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage b
Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today
06:51pm, Tuesday, 24'th Mar 2026
In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $32.17, denoting a -1.17% move from the preceding trading day.
